FanDuel launches Predicts app to target US prediction markets

FanDuel launched its prediction-market app, FanDuel Predicts, in partnership with CME Group and says it is now available in 16 states. The move expands FanDuel’s addressable U.S. market beyond regulated sports betting, but it also exposes the company to heightened regulatory scrutiny and ethical concerns around political and geopolitical wagering. Management said the product will avoid high-risk categories such as death, regime change, and war.

Analysis

FanDuel’s move is less about adding a new revenue line than about protecting distribution. Prediction markets lower the regulatory friction cost of keeping users inside the FanDuel ecosystem in states where traditional sportsbook economics are constrained, which makes this a customer-retention product first and a monetization product second. The second-order effect is that the company is trying to preempt a leakage problem: if users migrate to federally regulated markets for breadth or novelty, sportsbook incumbents risk losing the most active cohort even where they still hold legal gaming licenses.

The more important competitive angle is that CME gives the product institutional legitimacy and a path to scale that pure-gaming peers may struggle to replicate quickly. That creates a potential wedge where the winner is not the operator with the best sportsbook UX, but the one that can bridge consumer entertainment with exchange-style trust. Over the next 6-12 months, that could pressure DraftKings more than headline share gains suggest, because the market may start to discount a broader TAM expansion story for Flutter while DKNG remains more exposed to state-by-state saturation.

The bear case on the category is regulatory whiplash. Political-event and macro-event contracts invite scrutiny from multiple angles, and any high-profile insider-trading scandal or public backlash could slow product expansion for months, not days. That matters because the current enthusiasm is probably pricing in a clean rollout path; if regulators narrow permissible contract types, the addressable market shrinks materially and the product becomes a niche engagement tool rather than a growth engine.

The contrarian setup is that the market may be underestimating how little direct revenue this contributes near-term versus how much option value it adds to customer acquisition. That asymmetry favors CME on the distribution/clearing side and slightly hurts DKNG on narrative and multiple support. For now, the right framing is not 'prediction markets as a new sportsbook,' but 'prediction markets as a regulatory workaround that improves retention and broadens the funnel.'

Key Decisions for Investors

• Long CME on a 3-6 month horizon; the market may underappreciate the value of being the regulated partner in a category where trust and legal structure matter more than product novelty. Use weakness to add; downside is mainly regulatory backlash that slows adoption rather than breaks the thesis.
• Short DKNG vs long CME as a pair trade for 1-2 quarters; DKNG faces greater risk of narrative compression if investors start assigning more TAM share to federally regulated prediction products. Targeted if prediction-market headlines accelerate and DKNG struggles to show equivalent strategic optionality.
• Buy CME out-of-the-money calls 6-9 months out to express upside from a broader rollout without taking full equity beta; the convexity is attractive if the product gains traction in additional states faster than consensus expects.
• Avoid chasing the first spike in sentiment around Flutter/FanDuel; wait for evidence of retention lift or state expansion before adding. The near-term revenue contribution is likely modest, so the setup is more about strategic positioning than immediate EPS.
• Set a regulatory event alert on any CFTC or state attorney-general action; if enforcement broadens, trim CME and cover DKNG short quickly, as the category could re-rate lower within days.